Cleveland Jewish News: William Schiemann, associate professor of general medical sciences, led a team of researchers who found a link between a micro ribonucleic acid molecule and late-stage breast cancer. “Our micro RNA inactivates [a protein called] Bim, and we think this leads to chemo resistance to these metastatic cancers,” Schiemann said. Lower Bim levels, coupled with higher miR-181a levels, allow the spread of cancer.
Medicine’s William Schiemann and researchers target molecule’s role in late-stage breast cancer
- Volunteer at the National Senior Games, taking place on campus and around Cleveland this summer
- Law’s Jonathan Adler weighs in on petitions on climate regulation
- Lerner College’s Pedro Escobar discusses mutated BRCA gene
- Peter B. Lewis encourages 2,000 graduates at Sunday’s commencement ceremony
- Housing options available for summer